Granules India’s facilities in Vizag and Jeedimetla completes US FDA inspection

21 Dec 2015 Evaluate

Granules India’s two facilities located in Vizag in Andhra Pradesh and Jeedimetla in Telangana have completed U.S. Food and Drug Administration (US FDA) inspection. There are no observations for Vizag facility and 3 observations for Jeedimetla facility. The Company will respond to the observations in 15 business days.

Granules India is a fast growing pharmaceutical manufacturing company with world class facilities and is committed to manufacturing excellence, quality and customer service. The Company produces Finished Dosages (FDs), Pharmaceutical Formulation Intermediates (PFIs) and Active Pharmaceutical Ingredients (APIs) for quality conscious customers in the regulated and semi-regulated markets.

Granules India Share Price

558.90 13.45 (2.47%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.